STEICO SE: Preliminary figures confirmed by final financial statements 2023
EQS-News: STEICO SE / Key word: Annual Report STEICO SE: Preliminary figures confirmed by final financial statements 2023 02.05.2024 / 20:30 CET/CEST The issuer is...
Stay updated with breaking news from Andreas Schulze. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EQS-News: STEICO SE / Key word: Annual Report STEICO SE: Preliminary figures confirmed by final financial statements 2023 02.05.2024 / 20:30 CET/CEST The issuer is...
EQS-News: STEICO SE / Key word: Quarterly / Interim Statement STEICO: Correction to the corporate news from 19 April 2024. Net profit for the period Q1 2024: € 5.9 million;...
Drug trial results show that vaccines aren’t the only use for the mRNA technology behind the most widely used COVID-19 jabs. Drug trial results show that vaccines aren't the only use for the mRNA technology behind the most widely used COVID-19 jabs.
EQS-News: STEICO SE / Key word: Personnel STEICO SE: Paul O'Gorman elected Chairman of the STEICO Administrative Board 22.02.2024 / 20:30 CET/CEST The issuer is solely...
EQS-News: STEICO SE / Key word: Annual Results/Forecast STEICO: Preliminary business figures for 2023: Sales decline by 17.9% to € 365.3 million , EBIT ratio at 8.4% . Stable...